CBT's shares hit a 52-week high, fueled by strong segment growth, higher earnings and an upbeat outlook on robust market demand.
Cabot (CBT) is at a 52-week high, but can investors hope for more gains in the future? We take a look at the company's fundamentals for clues.
Here is how Cabot (CBT) and Vista Gold (VGZ) have performed compared to their sector so far this year.
Cabot (CBT) possesses solid growth attributes, which could help it handily outperform the market.
Here at Zacks, our focus is on the proven Zacks Rank system, which emphasizes earnings estimates and estimate revisions to find great stocks. Nevertheless, we are always paying attention to the latest value, growth, and momentum trends to underscore strong picks.
CBT's upside is fueled by strong segment performance, consistent earnings beat and an upbeat fiscal 2024 outlook.
Vertiv Holdings, Charles River, Cabot, Leidos Holdings and HCA Healthcare could be solid choices for a historically weak September.
CBT is poised for strong growth, driven by robust performance in its business segments on healthy demand.
Whether you're a value, growth, or momentum investor, finding strong stocks becomes easier with the Zacks Style Scores, a top feature of the Zacks Premium research service.
Here is how Cabot (CBT) and Element Solutions (ESI) have performed compared to their sector so far this year.
Cabot (CBT) could produce exceptional returns because of its solid growth attributes.
Here at Zacks, our focus is on the proven Zacks Rank system, which emphasizes earnings estimates and estimate revisions to find great stocks. Nevertheless, we are always paying attention to the latest value, growth, and momentum trends to underscore strong picks.